|
211 |
Postbiotic Supplementation Increases Amino Acid Absorption from Plant-Based Meal: A Placebo-Controlled, Randomized, Double-Blind, Crossover Study
Enthalten in Probiotics and Antimicrobial Proteins 24.2.2025: 1-15
|
|
|
|
212 |
Efficacy and safety of elobixibat in patients with chronic constipation—A randomized, multicenter, double-blind, placebo-controlled, parallel-group study from India
Enthalten in Indian journal of gastroenterology 22.2.2025: 1-9
|
|
|
|
213 |
Bacillus coagulans TBC169 probiotics for intestinal function recovery after gynecological open surgery: a randomized, double-blind, placebo-controlled trial
Enthalten in International journal of clinical pharmacy 20.2.2025: 1-9
|
|
|
|
214 |
Correction: The Effectiveness of Bromelain on Oedema, Subconjunctival Haemorrhage, and Ecchymosis After Rhinoplasty: A Randomised, Double-Blind, Placebo-Controlled Trial
Enthalten in Aesthetic plastic surgery 20.2.2025: 1
|
|
|
|
215 |
Efficacy and safety of patiromer for hyperkalemia: a randomized, placebo-controlled phase 3 study
Enthalten in Clinical and experimental nephrology 20.2.2025: 1-13
|
|
|
|
216 |
Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging Project
Enthalten in GeroScience 14.2.2025: 1-27
|
|
|
|
217 |
The Effectiveness of Bromelain on Oedema, Subconjunctival Haemorrhage, and Ecchymosis After Rhinoplasty: A Randomised, Double-Blind, Placebo-Controlled Trial
Enthalten in Aesthetic plastic surgery 4.2.2025: 1-10
|
|
|
|
218 |
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes
Enthalten in Pharmacopsychiatry 29.01.2025
|
|
|
|
219 |
Wie gut ist die Wirksamkeit der Low-Dose-Radiotherapie (LD-RT) für die Heberden-Arthrose? Eine Analyse der aktuellen Literatur
Enthalten in Zeitschrift für Orthopädie und Unfallchirurgie 27.01.2025
|
|
|
|
220 |
Ranolazine effectively improves clinical symptoms in patients with slow flow coronary arteries: a randomized, double-blind, placebo-controlled clinical trial
Enthalten in Naunyn-Schmiedeberg's archives of pharmacology 15.1.2025: 1-9
|
|
Administration
